In order to determine the impact of malignant transformation on cellular phospholipidome in colon adenocarcinoma cells, we next performed analyses of PLs and lysoPLs in purified primary tumor and non-tumor EpCAM+ cells. This evidence concerns the gene EPCAM and colon adenocarcinoma.